Neoantigen immunotherapy: a novel treatment for bladder cancer
Bladder cancer is currently the most common malignant tumor of the urinary system. The traditional treatment methods for bladder cancer are mainly surgery, chemotherapy, radiotherapy, and targeted therapy; however, these treatment methods do not improve the clinical prognosis of patients with advanc...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Open Exploration Publishing Inc.
2025-01-01
|
| Series: | Exploration of Targeted Anti-tumor Therapy |
| Subjects: | |
| Online Access: | https://www.explorationpub.com/uploads/Article/A1002288/1002288.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832586136205131776 |
|---|---|
| author | Ruiyang Lv Zhenzhu Liu Maoxin Lv Yuze Song Junlin Wang Huizhi Mu Yu Zhang Xuejian Wang |
| author_facet | Ruiyang Lv Zhenzhu Liu Maoxin Lv Yuze Song Junlin Wang Huizhi Mu Yu Zhang Xuejian Wang |
| author_sort | Ruiyang Lv |
| collection | DOAJ |
| description | Bladder cancer is currently the most common malignant tumor of the urinary system. The traditional treatment methods for bladder cancer are mainly surgery, chemotherapy, radiotherapy, and targeted therapy; however, these treatment methods do not improve the clinical prognosis of patients with advanced or metastatic bladder cancer. Consequently, there is an urgent need to develop new treatment methods to improve the survival rate and quality-of-life of patients with bladder cancer. Over recent years, the rapid development of tumor immunotherapy has become a significant alternative to traditional treatment, and provides new hope to patients. This review aims to introduce neoantigens and their possible role in the treatment of bladder cancer, and to explore the current limitations of neoantigens for the treatment of bladder cancer. |
| format | Article |
| id | doaj-art-78f1068fc7cb4f839885515be7150967 |
| institution | Kabale University |
| issn | 2692-3114 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Open Exploration Publishing Inc. |
| record_format | Article |
| series | Exploration of Targeted Anti-tumor Therapy |
| spelling | doaj-art-78f1068fc7cb4f839885515be71509672025-01-26T08:32:27ZengOpen Exploration Publishing Inc.Exploration of Targeted Anti-tumor Therapy2692-31142025-01-016100228810.37349/etat.2025.1002288Neoantigen immunotherapy: a novel treatment for bladder cancerRuiyang Lv0Zhenzhu Liu1Maoxin Lv2Yuze Song3Junlin Wang4Huizhi Mu5Yu Zhang6Xuejian Wang7Department of Urology, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province 116021, ChinaDepartment of Cardiovascular, Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province 116027, ChinaDepartment of Urology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan Province 650032, ChinaDepartment of Nursing, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province 116021, ChinaDepartment of Urology, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province 116021, ChinaDepartment of Urology, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province 116021, ChinaDepartment of Anesthesiology, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province 116021, ChinaDepartment of Urology, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province 116021, ChinaBladder cancer is currently the most common malignant tumor of the urinary system. The traditional treatment methods for bladder cancer are mainly surgery, chemotherapy, radiotherapy, and targeted therapy; however, these treatment methods do not improve the clinical prognosis of patients with advanced or metastatic bladder cancer. Consequently, there is an urgent need to develop new treatment methods to improve the survival rate and quality-of-life of patients with bladder cancer. Over recent years, the rapid development of tumor immunotherapy has become a significant alternative to traditional treatment, and provides new hope to patients. This review aims to introduce neoantigens and their possible role in the treatment of bladder cancer, and to explore the current limitations of neoantigens for the treatment of bladder cancer.https://www.explorationpub.com/uploads/Article/A1002288/1002288.pdfbladder cancerimmunotherapyneoantigens |
| spellingShingle | Ruiyang Lv Zhenzhu Liu Maoxin Lv Yuze Song Junlin Wang Huizhi Mu Yu Zhang Xuejian Wang Neoantigen immunotherapy: a novel treatment for bladder cancer Exploration of Targeted Anti-tumor Therapy bladder cancer immunotherapy neoantigens |
| title | Neoantigen immunotherapy: a novel treatment for bladder cancer |
| title_full | Neoantigen immunotherapy: a novel treatment for bladder cancer |
| title_fullStr | Neoantigen immunotherapy: a novel treatment for bladder cancer |
| title_full_unstemmed | Neoantigen immunotherapy: a novel treatment for bladder cancer |
| title_short | Neoantigen immunotherapy: a novel treatment for bladder cancer |
| title_sort | neoantigen immunotherapy a novel treatment for bladder cancer |
| topic | bladder cancer immunotherapy neoantigens |
| url | https://www.explorationpub.com/uploads/Article/A1002288/1002288.pdf |
| work_keys_str_mv | AT ruiyanglv neoantigenimmunotherapyanoveltreatmentforbladdercancer AT zhenzhuliu neoantigenimmunotherapyanoveltreatmentforbladdercancer AT maoxinlv neoantigenimmunotherapyanoveltreatmentforbladdercancer AT yuzesong neoantigenimmunotherapyanoveltreatmentforbladdercancer AT junlinwang neoantigenimmunotherapyanoveltreatmentforbladdercancer AT huizhimu neoantigenimmunotherapyanoveltreatmentforbladdercancer AT yuzhang neoantigenimmunotherapyanoveltreatmentforbladdercancer AT xuejianwang neoantigenimmunotherapyanoveltreatmentforbladdercancer |